We are live on ! Find out more
CG

Carlyle Group Portfolio holdings

AUM $10.6B
1-Year Est. Return 11.25%
This Fund
S&P 500
This Quarter Est. Return
-19.9%
1 Year Est. Return
+11.25%
3 Year Est. Return
-0.47%
5 Year Est. Return
-4.92%
10 Year Est. Return
+7.54%
AUM
$5.8B
AUM Growth
-$2.56B
Cap. Flow
-$952M
Cap. Flow %
-16.42%
Top 10 Hldgs %
100%
Holding
10
New
3
Increased
1
Reduced
1
Closed
1

Sector Composition

Rank Sector Weight
1 Materials 51.28%
2 Technology 23.89%
3 Healthcare 22.72%
4 Consumer Staples 1.89%
5 Industrials 0.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATC
1
DELISTED
Atotech Limited
ATC
$2.97B 51.28%
153,672,703
GTM
2
ZoomInfo Technologies
GTM
$922M
$1.39B 23.89%
41,671,145
-574,292
-1% -$25.3M
QDEL icon
3
QuidelOrtho
QDEL
$1.24B
$1.21B 20.88%
+12,460,183
New +$1.27B
VTRU
4
DELISTED
Vitru Limited Common Shares
VTRU
$109M 1.88%
6,246,471
ONEM
5
DELISTED
1Life Healthcare
ONEM
$107M 1.84%
13,612,681
SMHI icon
6
SEACOR Marine Holdings
SMHI
$212M
$6.89M 0.12%
1,196,649
+48,660
+4% +$385K
EM
7
DELISTED
Smart Share Global Ltd
EM
$5.34M 0.09%
+4,810,209
New +$6.01M
SPNT icon
8
SiriusPoint
SPNT
$2.92B
$701K 0.01%
129,408
AIU
9
DELISTED
Meta Data Limited American Depositary Shares, each representing ten (10) Class A Ordinary Shares
AIU
$465K 0.01%
+62,880
New +$484K
OCDX
10
DELISTED
Ortho Clinical Diagnostics Holdings plc Ordinary Shares
OCDX
-118,106,000
Closed -$2.2B

Similar funds

Carlyle Group's Q2 2022 Portfolio in Review

As of Q2 2022, Carlyle Group held 10 positions worth $5.8B, down 31% from $8.36B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Carlyle Group withdrew a net $952M in Q2 2022, closing 1 position and reducing 1 holding. Its most notable exit was Ortho Clinical Diagnostics Holdings plc Ordinary Shares, an estimated $2.2B position sold in full.

By sector, the portfolio is most concentrated in Materials at 51% of assets, up from 40% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Carlyle Group opened a new position in QuidelOrtho worth $1.21B.

  • Carlyle Group's largest Q2 2022 buy was QuidelOrtho: 12,460,183 shares worth $1.21B.
  • Carlyle Group added most to SEACOR Marine Holdings in Q2 2022, an estimated $385K increase.
  • Carlyle Group's biggest Q2 2022 reduction was ZoomInfo Technologies, cutting an estimated $25.3M.
  • Carlyle Group fully exited Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q2 2022, selling an estimated $2.2B.
  • Carlyle Group's ten largest holdings make up 100% of its $5.8B portfolio in Q2 2022.
  • Carlyle Group opened 3 new positions and closed 1 in Q2 2022.
  • Carlyle Group's portfolio value fell 31% quarter-over-quarter to $5.8B.

Based on Carlyle Group's 13F filing for Q2 2022, filed 12 Aug 2022.